|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 268.20 ILa | +2.80% |
|
-10.42% | -17.12% |
| 04-30 | InterCure Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| 03-03 | InterCure Receives Noncompliance Notice From Nasdaq | MT |
Sales 2025 by Business Segment
Sales 2025 by Geography
Historical Breakdown of Revenue by Business Segments
Operating Income: Breakdown by Business Segment
| Fiscal Period: December | 2016 | 2017 | 2018 (ILS) | 2019 (ILS) | 2020 (ILS) | 2021 (ILS) | 2022 (ILS) | 2023 (ILS) | 2024 (ILS) | 2025 (ILS) |
|---|---|---|---|---|---|---|---|---|---|---|
Medicinal Chemicals and Botanical Products | ||||||||||
Cannabis Segment | 220M | 389M | 356M | 239M | 270M | |||||
Total Assets | 582M | 886M | 755M | 732M | 690M | |||||
Operating Income | 44.65M | 68.55M | 44.46M | -39.7M | 14.36M | |||||
Operating Income | -1.87M | -174K | -665K | 341K | -2.03M | |||||
Net Income | - | - | - | - | - | |||||
D&A | - | - | - | - | - | |||||
EBT | - | - | - | - | - | |||||
CAPEX | - | - | - | - | - | |||||
Interest Expense | - | - | - | - | - | |||||
Total Assets | 2.9M | 2.77M | 2.06M | 2.4M | 214K | |||||
Reconciliations | - | - | - | - | - | |||||
Total Assets | 101M | 69.05M | 29.35M | 28.09M | - | |||||
Operating Income | - | - | - | - | - | |||||
Operating Income | -2.97M | -2.13M | -47.14M | - | - | |||||
Operating Income | -11.62M | -15.62M | -38.22M | -40.66M | -2.05M |
Geographical Revenue Distribution History
| Fiscal Period: December | 2016 | 2017 | 2018 (ILS) | 2019 (ILS) | 2020 (ILS) | 2021 (ILS) | 2022 (ILS) | 2023 (ILS) | 2024 (ILS) | 2025 (ILS) |
|---|---|---|---|---|---|---|---|---|---|---|
Israel | - | - | - | - | 262M | |||||
Germany | - | - | - | - | 8.15M |
- Stock Market
- Stocks
- INCR Stock
- Financials InterCure Ltd.
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
